Use the Back button in your browser to see the other results of your search or to select another record.
Vojta therapy improves postural control in very early stroke rehabilitation: a randomised controlled pilot trial |
Epple C, Maurer-Burkhard B, Lichti MC, Steiner T |
Neurological Research and Practice 2020 Aug 20;2(23):Epub |
clinical trial |
7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: It is still unclear, which physiotherapeutic approaches are most effective in stroke recovery. Vojta therapy is a type of physiotherapy that was originally developed for children and adolescents with cerebral palsy. Vojta therapy has been reported to improve automatic control of body posture. Because acute stroke patients are characterised by a disturbance in the ability to adapt to changes in body position, requiring automatic postural adjustment, we decided to investigate Vojta therapy in the early rehabilitation of stroke patients. Aim of the trial was to test the hypothesis that Vojta therapy -- as a new physiotherapeutic approach in early stroke recovery -- improves postural control and motor function in patients with acute ischaemic stroke (AIS) or intracerebral haemorrhage (ICH). METHOD(S): This prospective, randomised controlled trial included patients with imaging-confirmed AIS or ICH, severe hemiparesis and randomly assigned them to Vojta therapy or standard physiotherapy within 72 h after stroke onset. Main exclusion criterion was restricted ability to communicate. Primary endpoint was the improvement of postural control measured by the Trunk Control Test (TCT) on day 9 after admission. Secondary endpoint among others was improvement of arm function (measured with Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES)). RESULT(S): Forty patients (20 per group) were randomised into the trial. Median age was 75 (66 to 80) years, 50% were women. The median improvement in TCT within 9 days was 25.5 points (25.5%) (interquartile range (IQR) 12.5 to 42.5) in the Vojta group and 0 (IQR 0 to 13) in the control group (p = 0.001). Patients treated with Vojta therapy achieved a greater improvement in the MESUPES than patients in the control group (20% versus 10%, p = 0.006). CONCLUSION(S): This first randomised controlled trial of Vojta therapy in acute stroke patients demonstrates improvement of postural control through Vojta therapy compared to standard physiotherapy. Although this trial has some methodical weaknesses, Vojta therapy might be a promising approach in early stroke rehabilitation and should be studied in larger trials. TRIAL REGISTRATION: ClinicalTrials.gov; unique identifier NCT03035968. Registered 30 January 2017 -- retrospectively registered; http://www.ClinicalTrials.gov.
|